• 1
    Fontana RJ. Assessment of the newly diagnosed patient with chronic hepatitis B virus infection. Am J Med 2008; 121: S22S32.
  • 2
    Lok ASF, McMahon BJ. AASLD practice guideline: chronic hepatitis B. Hepatology 2009; 50: 135.
  • 3
    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 15221527.
  • 4
    Weiss J, Wu H, Farrenkopf B, Schultz T, Song G, Shah S, et al. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 2004; 30: 8693.
  • 5
    Chu CJ, Keefe, EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125: 444451.
  • 6
    Chu CJ, Hussain M, Lok ASF. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122: 17561762.
  • 7
    Yang HI Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, et al. Associations between hepatitis B virus genotype and mutants and risk of hepatocellular carcinoma. J Natl Can Institute 2008; 100: 11341141.
  • 8
    Wai CT, Fontana RJ. Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liv Dis 2004; 8: 321352.
  • 9
    Fung J, Lai CL, Young J, Wong DKH, Yuen J, Seto WK, et al. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment. Am J Gastroenterol 2011; 106: 17661773.
  • 10
    Koo JH, Lee MH, Kim SS, Kim DH, Kim IS, Lee KM, et al. Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy. Clin Biochem 2012; 45: 3136.
  • 11
    Castera L. Non-invasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 12931302.